Bracco Industria Chimica Spa, Milan: communications, in particular with the Bracco Delegation of Rome, concerning health problems that the administration of metamizole by intravenous route could cause; application for withdrawal of the registration of the medicinal speciality "Sistalgin compositum" ampoules.